
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia is facing intense competition from smaller, scaled, and well-capitalized participants in the healthcare market, but its strong partnerships and diversification efforts through the acquisition of AccessOne are potential growth drivers for the company. However, potential regulatory changes and ongoing litigation surrounding the ConnectOnCall outage pose risks to the company's reputation and business. Despite industry headwinds, Phreesia is expected to maintain its efficient operations and emerge as a higher margin, diversified company.
Bears say
Phreesia is facing several concerning factors that may negatively impact its financial performance. The company has a heavy reliance on its subscription and related services revenue, which has been growing at a slower rate than previously expected. Additionally, the company is facing headwinds in the form of a patent cliff and increasing competition for healthcare advertising budgets. The recent reduction in guidance for its network solutions revenue also raises concerns about the company's ability to maintain growth and profitability. With a relatively high valuation compared to its peers and uncertainties around future growth, a negative outlook is warranted for Phreesia's stock.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares